Testing PG-102 for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medication called PG-102 for people with type 2 diabetes. It compares PG-102 to a placebo (inactive treatment) and semaglutide (a standard diabetes drug) to see if it can help lower blood sugar and potentially help with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with type 2 diabetes for at least 6 months.
- Your HbA1c (a measure of blood sugar control over the past few months) is between 7.0% and 10.0%.
- Your body mass index (BMI) is between 25 and 39.9.
- You are not currently taking any other diabetes medications besides metformin (if any).
- You have not used GLP-1 medications (like Ozempic or Wegovy) in the last 3 months, and have never had an allergic reaction to them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called bofanglutide in adults with type 2 diabetes who are currently taking metformin. The medication works similarly to a hormone that helps control blood sugar, and the study aims to see if it can help lower blood sugar levels and manage weight better.
This trial tests an investigational drug called BGM0504 in people with type 2 diabetes who are already taking metformin or metformin plus another diabetes medicine. It aims to see if the drug can help lower blood sugar levels.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This study tests switching from dulaglutide (a once-weekly diabetes shot) to a new similar shot called PG-102. It may help people whose blood sugar is well-controlled on dulaglutide but want to try a different option.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.